Recurrent Atrial Fibrillation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02898545

Acronym

Recurrent AF

Enrollment

Registered

2016-09-13

Start date

2016-09-30

Completion date

2017-07-20

Last updated

2017-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

This study will evaluate the recurrence rates of atrial fibrillation that develops in the hospital following non cardiac procedures or surgeries or acute medical illnesses.

Detailed description

Eligible individuals with no previous history of atrial fibrillation or flutter who develop a limited episode of atrial fibrillation during a hospital stay for an acute medical illness or non-cardiothoracic surgery or procedure. Patients will be monitored for a period of 1 month using Medtronic SEEQ monitors for recurrence. Subjects will self assign to wear the SEEQ monitor or standard of care. Individuals with implanted cardiac devices capable of detecting atrial fibrillation will also be included.

Interventions

DEVICESEEQ monitor

An external cardiac rhythm monitor

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Development of atrial fibrillation or flutter during a hospital stay following a non-cardiac procedure or acute medical illness * CHADS2VASc score of 2 or more

Exclusion criteria

* Prior history of atrial fibrillation of flutter * Requiring ventilator support or in shock * Acute decompensated heart failure or EF =/\< 40% * Greater than mild valvular heart disease * Other structural heart disease such as more than mild LVH, constrictive or restrictive cardiomyopathy * Hyperthyroidism uncontrolled at the time of diagnosis if known * Pulmonary embolism that requires thrombolysis or resulted in shock * Use of antiarrhythmic drugs (class I or III) at the time of discharge * Cardiothoracic surgery in the last 6 months

Design outcomes

Primary

Measure	Time frame	Description
Recurrence of atrial fibrillation	28 days	The rate of recurrence of atrial fibrillation will be compared to the recurrence noted in the standard of care arm.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026